# Study of Efavaleukin Alfa in Healthy Chinese, Japanese, and Caucasian Participants

> **NCT04987333** · PHASE1 · COMPLETED · sponsor: **Amgen** · enrollment: 32 (actual)

## Conditions studied

- Inflammatory Diseases

## Interventions

- **DRUG:** Efavaleukin alfa

## Key facts

- **NCT ID:** NCT04987333
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-09
- **Primary completion:** 2022-10-03
- **Final completion:** 2022-10-03
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2024-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04987333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04987333, "Study of Efavaleukin Alfa in Healthy Chinese, Japanese, and Caucasian Participants". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04987333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*